Opportunity ID: 333861

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-21-NETP-IIRA
Funding Opportunity Title: Neurotoxin Exposure Treatment Parkinson’s, Investigator- Initiated Research Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 3
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 27, 2021
Last Updated Date: May 28, 2021
Original Closing Date for Applications: Sep 29, 2021
Current Closing Date for Applications: Sep 29, 2021
Archive Date: Oct 29, 2021
Estimated Total Program Funding: $16,000,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The NETP Program IIRA supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to neurotoxin exposure and treatment-related Parkinson’s research. This award mechanism supports the full spectrum of research from basic science through clinical research.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date
The package has been updated to replace the original UEI package with DUNs package. May 28, 2021
May 27, 2021

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-21-NETP-IIRA
Funding Opportunity Title: Neurotoxin Exposure Treatment Parkinson’s, Investigator- Initiated Research Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 3
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 27, 2021
Last Updated Date: May 28, 2021
Original Closing Date for Applications: Sep 29, 2021
Current Closing Date for Applications: Sep 29, 2021
Archive Date: Oct 29, 2021
Estimated Total Program Funding: $16,000,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The NETP Program IIRA supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to neurotoxin exposure and treatment-related Parkinson’s research. This award mechanism supports the full spectrum of research from basic science through clinical research.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-21-NETP-IIRA
Funding Opportunity Title: Neurotoxin Exposure Treatment Parkinson’s, Investigator- Initiated Research Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 3
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 27, 2021
Last Updated Date: May 27, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Sep 29, 2021
Archive Date: Oct 29, 2021
Estimated Total Program Funding: $16,000,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The NETP Program IIRA supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to neurotoxin exposure and treatment-related Parkinson’s research. This award mechanism supports the full spectrum of research from basic science through clinical research.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Folder 333861 Full Announcement-FY21 NETP IIRA -> NETP_FY21_IIRA_PA_GG.pdf

Packages

Agency Contact Information: CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00267425 May 27, 2021 Sep 29, 2021 View

Package 1

Mandatory forms

333861 RR_SF424_3_0-3.0.pdf

333861 AttachmentForm_1_2-1.2.pdf

333861 RR_PersonalData_1_2-1.2.pdf

333861 RR_KeyPersonExpanded_3_0-3.0.pdf

333861 RR_Budget_1_4-1.4.pdf

333861 PerformanceSite_3_0-3.0.pdf

Optional forms

333861 RR_SubawardBudget30_1_4-1.4.pdf

2025-07-11T10:11:16-05:00

Share This Post, Choose Your Platform!

About the Author: